---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013648"
form_type: "8-K/A"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:29:36.165016+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Processa shareholders approve 10x authorized share increase and reverse split

## Summary
- Shareholders approved increase in authorized common shares from 100M to 1B (13.7M for, 3.0M against).
- Reverse stock split approved with ratio ranging from 1:2 to 1:50, at board's discretion, by Dec 31, 2026.
- Amendment to 2019 Omnibus Incentive Plan to increase shares available for issuance approved (13.6M for).
- All four proposals passed at special meeting held Sep 11, 2025.

## SEC filing metadata
- accession: 0001493152-25-013648
- form_type: 8-K/A
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/0001493152-25-013648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013648
- JSON: https://secwatch.observer/filing/0001493152-25-013648.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013648.txt

## Key facts
- Governance Changes
  Processa Pharmaceuticals, Inc.: The Company filed an amendment to its Fourth Amended and Restated Certificate of Incorporation to increase authorized common stock from 100,000,000 shares to 1,000,000,000 shares (effective 2025-09-12).
  - Change: charter amendment
  - Effective: 2025-09-12
  source text: Effective September 12, 2025, Processa Pharmaceuticals, Inc. (the “Company” or “us” or “we”) filed an amendment to its Fourth Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of common stock from 100,000,000 shares to 1,000,000,000 shares (the “Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/0001493152-25-013648-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.